Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.
Also called NCT02592980
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 300 participants
- Registry
-
NCT02592980
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Brazil
- Registry status
- Unknown status
Technical summary
Registry record NCT02592980. Randomized; single masking; primary purpose treatment. Start 2016-01 (actual); primary completion 2019-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients
- Condition
- Atrial Fibrillation
- Intervention (Genetic)
- Pharmacogenetic anticoagulation
- Intervention (Drug)
- Traditional anticoagulation
- Lead sponsor
- University of Sao Paulo General Hospital
- Collaborator
- InCor Heart Institute
- Collaborator
- Farmoquimica S.A.
- Collaborator
- University of Sao Paulo
Record details
- Record id
cardio:ct-nct02592980- Content hash
884bcfbcb0ed885468a177e68808df02b1986b4f8621247937fd62f15702a311